These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19581351

  • 1. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, Ishimatsu Y, Kawakami A, Eguchi K, Kohno S.
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [Abstract] [Full Text] [Related]

  • 2. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [Abstract] [Full Text] [Related]

  • 3. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, Guo Q, Yang CD, Gu YY, Bao CD, Chen SL.
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [Abstract] [Full Text] [Related]

  • 4. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S, Arita M, Morita M, Ikeo S, Ito A, Tokioka F, Noyama M, Misaki K, Notohara K, Ishida T.
    BMC Pulm Med; 2015 Dec 09; 15():159. PubMed ID: 26651481
    [Abstract] [Full Text] [Related]

  • 5. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis].
    Lin H, Liang Y, Wang Y, Cen XM, Yin G, Xie QB.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep 09; 44(5):805-9. PubMed ID: 24325117
    [Abstract] [Full Text] [Related]

  • 6. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.
    Ji Q, Pan W, Zhang D, Hou Y, Wang Z.
    Front Immunol; 2023 Sep 09; 14():1237209. PubMed ID: 38098481
    [Abstract] [Full Text] [Related]

  • 7. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    Arthritis Care Res (Hoboken); 2016 May 09; 68(5):689-94. PubMed ID: 26414240
    [Abstract] [Full Text] [Related]

  • 8. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Oga T, Chin K, Nagai S, Mimori T, Mishima M.
    Respir Med; 2011 Sep 09; 105(9):1380-7. PubMed ID: 21632230
    [Abstract] [Full Text] [Related]

  • 9. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 09; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 10. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ, Park JK, Kang EH, Kwon HM, Lee YJ, Song YW, Lee EB.
    Rheumatol Int; 2016 Jan 09; 36(1):125-31. PubMed ID: 26223808
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for myositis-associated interstitial lung disease.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, Inui N, Yokomura K, Koshimizu N, Toyoshima M, Shirai T, Yasuda K, Hayakawa H, Suda T.
    PLoS One; 2014 Jan 09; 9(6):e98824. PubMed ID: 24905449
    [Abstract] [Full Text] [Related]

  • 12. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

  • 13. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review.
    McPherson M, Economidou S, Liampas A, Zis P, Parperis K.
    Semin Arthritis Rheum; 2022 Apr 03; 53():151959. PubMed ID: 35134633
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ, Li YH, Zhang LH, Ma L, He WW, Jin YB, An Y, Li ZG, Ye H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec 18; 52(6):1001-1008. PubMed ID: 33331305
    [Abstract] [Full Text] [Related]

  • 15. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y, Fu Q, Wang R, Guo Q, Bao C.
    J Clin Lab Anal; 2019 Oct 18; 33(8):e22978. PubMed ID: 31301087
    [Abstract] [Full Text] [Related]

  • 16. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
    Koyama RVL, Braga TKK, da Silva Dias GA, Fujihara S, Fuzii HT, Yoshikawa GT.
    Clin Rheumatol; 2017 Aug 18; 36(8):1919-1926. PubMed ID: 28488124
    [Abstract] [Full Text] [Related]

  • 17. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
    Horiike Y, Suzuki Y, Fujisawa T, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Ogawa N, Suda T.
    Rheumatology (Oxford); 2019 Dec 01; 58(12):2143-2152. PubMed ID: 31143953
    [Abstract] [Full Text] [Related]

  • 18. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD.
    J Am Acad Dermatol; 2006 Apr 01; 54(4):597-613. PubMed ID: 16546580
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
    Gil B, Merav L, Pnina L, Chagai G.
    Clin Rheumatol; 2016 Aug 01; 35(8):2125-2130. PubMed ID: 25846833
    [Abstract] [Full Text] [Related]

  • 20. Interstitial lung diseases associated with amyopathic dermatomyositis.
    Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, Hashimoto D, Sato J, Toyoshima M, Hashizume H, Chida K.
    Eur Respir J; 2006 Nov 01; 28(5):1005-12. PubMed ID: 16837503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.